Swedish Study Finds SARS-CoV-2 Papain-Like Protease Linked to Disruption in Cellular Recycling
Nikhil Prasad Fact checked by:Thailand Medical News Team Dec 31, 2024 2 days, 22 hours, 17 minutes ago
Medical News: A team of researchers from Karolinska Institutet in Stockholm, Sweden, has unveiled groundbreaking insights into the intricate ways SARS-CoV-2, the virus behind COVID-19, manipulates human cellular processes. The study, led by Carlos Ayala Torres, Jiangnan Liu, Nico P. Dantuma, and Maria G. Masucci, delves into how a specific viral protein, the papain-like protease (PLpro), interferes with autophagy - the cell’s natural recycling system. Autophagy is essential for clearing damaged components and defending against pathogens. This
Medical News report explores the study’s findings and their implications.
.jpg)
Swedish Study Finds SARS-CoV-2 Papain-Like Protease Linked to Disruption in Cellular Recycling
Understanding the Role of PLpro in Viral Infections
PLpro is a multifunctional protein encoded by SARS-CoV-2, embedded within the virus’s nonstructural protein 3 (Nsp3). While its primary role involves processing viral polyproteins to support replication, PLpro also exhibits deubiquitinase activity. This means it can reverse specific cellular modifications by cleaving ubiquitin and ubiquitin-like proteins such as ISG15. Through this function, PLpro interacts with numerous cellular pathways, enabling the virus to evade immune responses and manipulate host processes.
The researchers focused on understanding how PLpro interacts with components of autophagy, particularly N-recognin ubiquitin ligases. These ligases identify proteins tagged for degradation based on specific signals, such as N-degrons. N-degrons are degradation signals exposed at the protein’s N-terminus due to stress or cleavage. The researchers’ work revealed surprising details about PLpro’s ability to modulate autophagy pathways in ways that benefit viral survival.
Mechanisms Explored in the Study
The study employed advanced mass spectrometry techniques to analyze the interactions between PLpro and various cellular components. By isolating the active catalytic domain of PLpro and a mutated version lacking enzymatic activity, the team could pinpoint how the viral protein influences cellular pathways. They observed that PLpro stabilizes certain N-degron substrates, preventing their degradation by the proteasome - a structure responsible for breaking down unwanted proteins.
The study highlights that one such substrate is HSPA5/BiP/GRP78, a chaperone protein critical for managing cellular stress. HSPA5 is released from the endoplasmic reticulum (ER) during stress and undergoes modifications, including arginylation, to form a type I N-degron. PLpro was shown to enhance the oligomerization of SQSTM1/p62, an adaptor protein pivotal in assembling autophagic structures. This interaction promotes the clustering of proteins and lipids necessary for autophagosome formation - but in a manner that may hinder the cell’s defense against viral invasion.
Key Findings of the Study
-Stabilization of N-Degron Substrates:
PLpro selectively stabilizes proteins with N-degrons, such as HSPA5, rescuing them from proteasomal degradation.
The study demonstrated that this stabilization involves PLpro’s enzymatic removal of ubiquitin chains linked to these substrates.
-Altered Autophagy Dynamics:
PLpro’s interaction with SQSTM1/p62 enhances the aggregation of this adaptor protein. Such aggregates, while typically useful in autophagy, are repurposed by SARS-CoV-2 for its replication.
PLpro interferes with key steps in autophagy, notably impairing the lipidation of LC3, a protein essential for autophagosome maturation.
-Disruption of Reticulophagy:
Reticulophagy, a specialized form of autophagy targeting ER membranes, is inhibited by PLpro. The researchers used fluorescent reporters to confirm that PLpro disrupts the fusion of autophagosomes with lysosomes, effectively halting the recycling process.
-Selective Recruitment of Autophagy Machinery:
While PLpro promotes the early assembly of autophagy-related structures, it fails to recruit critical components like the ATG12–ATG5-ATG16L1 complex or lipidated LC3, leading to incomplete autophagosomes.
Implications of the Findings
The findings offer critical insights into how SARS-CoV-2 manipulates autophagy for its benefit. By stabilizing N-degron substrates like HSPA5 and disrupting the regular autophagy process, PLpro helps the virus maintain a favorable environment for replication. Furthermore, the study underscores the intricate balance between viral survival strategies and the host cell’s defense mechanisms.
The ability of PLpro to interfere with autophagy also opens new avenues for therapeutic intervention. Inhibiting PLpro’s enzymatic activity could restore normal autophagy, enhancing the cell’s ability to counteract the virus. This approach might complement existing antiviral strategies, especially for patients experiencing severe COVID-19 symptoms linked to heightened cellular stress.
Conclusions
The study conducted by the Karolinska Institutet team sheds light on the sophisticated mechanisms employed by SARS-CoV-2 to hijack host cellular processes. PLpro, a key viral enzyme, not only facilitates viral replication but also disrupts autophagy by stabilizing N-degron substrates and interfering with autophagic machinery. This dual role highlights PLpro as a crucial target for therapeutic development.
By modulating autophagy, SARS-CoV-2 enhances its ability to replicate and evade immune responses. The findings suggest that restoring normal autophagic pathways through targeted therapies could mitigate the virus’s effects. With its detailed exploration of PLpro’s interactions and impacts, the study provides a foundation for future research into antiviral treatments.
The study findings were published in the peer-reviewed journal: Autophagy.
https://www.tandfonline.com/doi/full/10.1080/15548627.2024.2442849
For the latest COVID-19 News, keep on logging to Thailand
Medical News.
Read Also:
https://www.thailandmedical.news/news/russian-study-finds-that-myelin-basic-protein-antagonizes-sars-cov-2-orf3a-induced-autophagy-inhibition
https://www.thailandmedical.news/news/unraveling-the-intricacies-of-sars-cov-2-evolution-the-role-of-envelope-protein-mutation-t9i-in-autophagy-resistance
https://www.thailandmedical.news/news/sars-cov-2-causes-downregulation-of-autophagy-genes-pik3c3-and-rab7a
https://www.thailandmedical.news/articles/coronavirus
Share
Tweet
Share
